Autosplenectomy and antiphospholipid antibodies in systemic lupus erythematosus: A pathogenetic relationship?

Semin Arthritis Rheum. 2003 Oct;33(2):125-33. doi: 10.1016/s0049-0172(03)00004-0.

Abstract

Objectives: To describe a systemic lupus erythematosus (SLE) patient with functional asplenia and antiphospholipid syndrome (APS) and to review the literature to better define its pathogenesis and diagnosis, emphasizing a possible relationship with antiphospholipid antibodies (aPL).

Methods: Descriptive report of 1 case and review of the literature by means of a MEDLINE search from 1966 to 2002.

Results: A SLE patient presented with cutaneous vasculitis and an unexpected thrombocytosis which resulted from autosplenectomy. Subsequently, she developed full-blown APS. In the literature, autosplenectomy has been described only in 1 other case of APS secondary to SLE. However, clinical or laboratory features linked to aPL occurred in several other cases among the 17 cases reported with functional asplenia.

Conclusions: Autosplenectomy in SLE may be pathogenetically related to aPL. Thrombocytosis, unusual in SLE, may be a diagnostic clue of this condition. Pneumococcal vaccination is warranted to prevent life-threatening infections that frequently complicate this asplenia.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antibodies, Antiphospholipid / immunology*
  • Antiphospholipid Syndrome / complications*
  • Antiphospholipid Syndrome / immunology
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / complications*
  • Skin Diseases, Vascular / immunology
  • Splenic Diseases / immunology*
  • Thrombocytosis / immunology

Substances

  • Antibodies, Antiphospholipid